Aug 5, 2024, 07:40
Dual Role of Protein in cancer treatment
Cancer Research Institute shared an article by Denise Heady, on LinkedIn:
“In a new study published in Cell Press‘ Cell Reports, investigators from UCLA Health Jonsson Comprehensive Cancer Center, including CRI Scientific Advisory Council member Dr. Antoni Ribas, reveal how a protein called interferon regulatory factor (IRF1) can ‘both hinder and help the body’s immune response to tumors, depending on which cells the protein is found in.’ Understand how researchers aim to translate their findings into immunotherapy treatments, and to ultimately improve outcomes for cancer patients.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 13:40
Dec 21, 2024, 13:33
Dec 21, 2024, 13:20
Dec 21, 2024, 13:12
Dec 21, 2024, 13:05